HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Sercan Aksoy Selected Research
Sercan Aksoy Research Topics
Disease
54
Neoplasms (Cancer)
08/2022 - 01/2004
40
Breast Neoplasms (Breast Cancer)
01/2022 - 01/2004
17
Neoplasm Metastasis (Metastasis)
02/2022 - 11/2005
8
Cardiotoxicity
09/2021 - 05/2005
6
Prostatic Neoplasms (Prostate Cancer)
01/2021 - 01/2015
6
Triple Negative Breast Neoplasms
01/2020 - 04/2009
6
Colorectal Neoplasms (Colorectal Cancer)
03/2015 - 01/2013
6
Lymphoma (Lymphomas)
03/2009 - 04/2004
5
Infections
01/2021 - 01/2006
5
Carcinoma (Carcinomatosis)
01/2017 - 10/2006
5
Stomach Neoplasms (Stomach Cancer)
02/2016 - 01/2011
4
Disease Progression
10/2021 - 01/2012
4
Osteoporosis
01/2016 - 03/2011
3
Obesity
01/2016 - 01/2006
3
Adenocarcinoma
01/2014 - 01/2010
3
Non-Hodgkin Lymphoma (Lymphosarcoma)
03/2009 - 07/2007
2
Renal Cell Carcinoma (Grawitz Tumor)
08/2022 - 09/2021
2
Acute Kidney Injury (Acute Renal Failure)
06/2022 - 01/2013
2
Head and Neck Neoplasms (Head and Neck Cancer)
01/2022 - 06/2021
2
Rheumatic Diseases (Rheumatism)
01/2021 - 02/2019
2
Squamous Cell Carcinoma of Head and Neck
06/2020 - 01/2017
2
Hematologic Neoplasms (Hematological Malignancy)
02/2019 - 01/2005
2
Heart Failure
03/2015 - 12/2014
2
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
07/2014 - 08/2006
2
Hepatitis C
06/2014 - 05/2008
2
Chronic Hepatitis (Chronic Active Hepatitis)
06/2014 - 05/2008
2
Hodgkin Disease (Hodgkin's Disease)
01/2014 - 03/2008
2
Colonic Neoplasms (Colon Cancer)
01/2014 - 03/2005
2
Atrial Fibrillation
01/2013 - 03/2011
2
Pancreatic Neoplasms (Pancreatic Cancer)
11/2012 - 01/2012
2
Nasopharyngeal Carcinoma
01/2012 - 01/2004
Drug/Important Bio-Agent (IBA)
13
Trastuzumab (Herceptin)
FDA Link
01/2022 - 01/2012
8
Doxorubicin (Adriamycin)
FDA Link
Generic
02/2015 - 01/2004
7
Hormones (Hormone)
IBA
08/2021 - 05/2008
7
Fluorouracil (Carac)
FDA Link
Generic
01/2017 - 03/2005
6
Immune Checkpoint Inhibitors
IBA
06/2022 - 03/2020
6
Aromatase Inhibitors
IBA
01/2022 - 10/2008
6
Anthracyclines
IBA
09/2021 - 10/2014
6
pertuzumab
IBA
07/2021 - 01/2012
6
Capecitabine (Xeloda)
FDA Link
07/2015 - 03/2005
6
Rituximab (Mabthera)
FDA Link
06/2014 - 03/2006
5
ErbB Receptors (EGF Receptor)
IBA
01/2016 - 01/2012
5
Diphosphonates (Bisphosphonates)
IBA
01/2013 - 01/2004
4
Paclitaxel (Taxol)
FDA Link
Generic
01/2022 - 05/2005
4
taxane
IBA
07/2021 - 04/2013
4
Cisplatin (Platino)
FDA Link
Generic
01/2017 - 01/2004
4
Zoledronic Acid (Zometa)
FDA Link
01/2016 - 01/2008
4
Oxaliplatin (Eloxatin)
FDA Link
Generic
09/2014 - 01/2011
4
Leucovorin (Folinic Acid)
FDA Link
09/2014 - 01/2010
4
Ifosfamide
FDA Link
Generic
01/2012 - 01/2004
3
Pharmaceutical Preparations
IBA
06/2022 - 01/2011
3
Biomarkers (Surrogate Marker)
IBA
05/2022 - 03/2015
3
L-Lactate Dehydrogenase (Lactate Dehydrogenase)
IBA
09/2021 - 01/2014
3
exemestane (Aromasin)
FDA Link
07/2021 - 01/2014
3
Everolimus
FDA Link
07/2021 - 01/2014
3
abiraterone
IBA
01/2021 - 05/2019
3
Docetaxel (Taxotere)
FDA Link
01/2017 - 09/2014
3
Lapatinib (GW572016)
FDA Link
06/2014 - 04/2013
3
Bevacizumab (Avastin)
FDA Link
01/2014 - 01/2011
3
Platinum
IBA
11/2013 - 01/2004
2
pembrolizumab
IBA
10/2021 - 06/2020
2
Androgen Receptors (Androgen Receptor)
IBA
01/2021 - 09/2018
2
RNA (Ribonucleic Acid)
IBA
01/2020 - 05/2008
2
Abiraterone Acetate
IBA
10/2019 - 05/2019
2
Tyrosine Kinase Inhibitors
IBA
01/2016 - 06/2014
2
TOR Serine-Threonine Kinases
IBA
01/2016 - 06/2014
2
Tamoxifen
FDA Link
Generic
01/2016 - 01/2004
2
C-Reactive Protein
IBA
03/2015 - 10/2009
2
Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)
IBA
03/2015 - 02/2014
2
Cytotoxins (Cytolysins)
IBA
02/2015 - 04/2013
2
Phenobarbital (Luminal)
FDA Link
01/2015 - 04/2009
2
Cyclophosphamide (Cytoxan)
FDA Link
Generic
01/2015 - 07/2007
2
Imatinib Mesylate (Gleevec)
FDA Link
06/2014 - 01/2013
2
Adrenal Cortex Hormones (Corticosteroids)
IBA
06/2014 - 05/2008
2
Vitamin D
FDA Link
Generic
01/2014 - 01/2004
2
Vincristine (Oncovin)
FDA Link
Generic
01/2014 - 11/2005
2
Ado-Trastuzumab Emtansine
IBA
08/2013 - 04/2013
2
Monoclonal Antibodies
IBA
08/2013 - 07/2007
2
Peptides (Polypeptides)
IBA
01/2013 - 10/2009
2
Estrogens (Estrogen)
FDA Link
01/2011 - 01/2004
2
Biological Products
IBA
05/2008 - 01/2007
1
Thrombospondins
IBA
08/2022
1
Transfer RNA (tRNA)
IBA
02/2022
1
Glycine (Aminoacetic Acid)
FDA Link
Generic
02/2022
1
Glutamic Acid (Glutamate)
FDA Link
02/2022
1
Isoleucine (L-Isoleucine)
FDA Link
02/2022
1
Aspartic Acid (Aspartate)
FDA Link
02/2022
1
Arginine (L-Arginine)
FDA Link
02/2022
Therapy/Procedure
34
Drug Therapy (Chemotherapy)
10/2021 - 01/2004
26
Therapeutics
08/2022 - 01/2005
11
Radiotherapy
01/2022 - 03/2008
8
Immunotherapy
06/2022 - 01/2016
4
Chemoradiotherapy
01/2015 - 01/2010
3
Neoadjuvant Therapy
07/2021 - 10/2012
3
Castration
01/2021 - 05/2019
2
Polypharmacy
06/2022 - 04/2021
2
Gastrectomy
02/2016 - 10/2012
2
Duration of Therapy
03/2015 - 12/2014
2
Adjuvant Chemotherapy
10/2014 - 01/2013
1
Inappropriate Prescribing
06/2022